Depreciation of NeuroPace Inc from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NeuroPace Inc quarterly and annual Depreciation in USD history and change rate from 31 Mar 2020 to 31 Dec 2025.
  • NeuroPace Inc Depreciation for the quarter ending 31 Dec 2025 was $11,000, a 71% increase year-over-year.
  • NeuroPace Inc Depreciation for the twelve months ending 31 Dec 2025 was $238,000, a 15% increase year-over-year.
  • NeuroPace Inc annual Depreciation for 2025 was $238,000, a 15% increase from 2024.
  • NeuroPace Inc annual Depreciation for 2024 was $207,000, a 20% increase from 2023.
  • NeuroPace Inc annual Depreciation for 2023 was $172,000, a 36% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

NeuroPace Inc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $238,000 $11,000 +$27,000 +71% 01 Oct 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $211,000 $100,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $211,000 $100,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $211,000 $49,000 +$4,000 +8.9% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $207,000 $38,000 +$38,000 +50% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $169,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $169,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $169,000 $45,000 -$3,000 -6.2% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $172,000 $76,000 -$63,000 -485% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $235,000 $100,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $235,000 $100,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $235,000 $48,000 -$32,000 -40% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $267,000 $13,000 -$35,000 -159% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $302,000 $100,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $302,000 $100,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $302,000 $80,000 +$6,000 +8.1% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $296,000 $22,000 -$8,000 -27% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $304,000 $100,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $304,000 $100,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $304,000 $74,000 -$8,000 -9.8% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $312,000 $30,000 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $100,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $100,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $82,000 01 Jan 2020 31 Mar 2020 10-Q 03 Jun 2021 2021 Q1

NeuroPace Inc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $238,000 +$31,000 +15% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $207,000 +$35,000 +20% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $172,000 -$95,000 -36% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $267,000 -$29,000 -9.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $296,000 -$16,000 -5.1% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $312,000 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.